Loading
Latest filing published 21 Nov 2022 for Aerie Pharmaceuticals INC, €683k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Peter Frederick Lang is a declared insider of Aerie Pharmaceuticals Inc (finance chief), with filings sourced from SEC (Form 4). In total, 2 filings cover trades dated from 18 March 2022 to 21 November 2022.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 21 November 2022, the filings show a transaction worth €683k in Aerie Pharmaceuticals Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations